WHO receives data from the Pfizer-BioNTech Covid-19 vaccine
Mike Ryan, WHO’s top emergency expert, welcomed the news, adding: We shouldn’t stop, we need more than 3-4 vaccines. We need to increase production
The World Health Organization said on Wednesday it had received data from Pfizer and BioNTech on the Covid-19 vaccine and was reviewing it for possible listing for emergency use, a benchmark for countries to authorize national use.
Referring to Britain’s regulator, the Medicines and Healthcare products Regulatory Agency, it said in a statement, WHO is also in discussions with MHRA on the possibility of accessing some of the information from their assessment, which could expedite WHO’s emergency listing.
Britain approved Pfizer Covid-19 vaccine on Wednesday, jumping ahead of the United States and Europe to become the West’s first country to formally endorse a shot it said should reach the most vulnerable people early next week.
